Semaglutide is available to Albuquerque, New Mexico residents through Weight Method's telehealth platform. In the Southwest, where summer temperatures regularly exceed 100 degrees and limit outdoor exercise, a medication-based approach to weight loss is both practical and clinically sound. Semaglutide (Ozempic / Wegovy) has demonstrated 15-20% of body weight average body weight loss in trials, and Weight Method delivers it to your door starting at $199/month.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Albuquerque is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Albuquerque, NM. Weight Method offers compounded semaglutide, prescribed by licensed providers, from $199/month with virtual consultations and direct-to-door shipping.
Semaglutide works by mimicking incretin hormones that your body naturally produces after eating. It activates receptors in the brain that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. For Albuquerque residents, Weight Method makes its compounded Semaglutide program accessible through telehealth — a virtual consultation with a licensed provider, your prescription shipped to your door, and ongoing clinical support. Individual response varies, and your provider sets expectations based on your clinical profile rather than on brand-product trial figures.
Albuquerque's multilingual population deserves Semaglutide treatment that does not require a translator or a compromise. Weight Method's virtual consultations, patient resources, and dosage guides are all available in both English and Spanish. Combined with Semaglutide's clinical efficacy — 15-20% of body weight average weight loss — this represents accessible, high-quality obesity care for all of Albuquerque.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in New Mexico and start Semaglutide from $199/month.
Get Started NowFree consultation. No commitment.